CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 436 enrolled
Drug / intervention
Transonicdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02376361
NCT02376361N/ACompleted
CompareCT.gov

Hemodialysis Access Surveillance Evaluation Study

Albany Medical College·interventional·Posted Mar 3, 2015·Updated Feb 23, 2021

In Brief

A clinical study evaluating Transonic for Hemodialysis Access and Thrombosis. Completed, enrolled 436 participants across 3 sites.

Detailed Summary

The purpose of the study is to learn if monitoring dialysis access blood flow during dialysis treatment with a transonic machine (an ultrasound technique) will prevent (or reduce) the development of dialysis access thrombosis (clotting). Investigators would like to study if monitoring with a specific technique called ultrasound dilution technique can help prevent problems with access when compared to what is the current standard of care for patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemodialysis Access, Thrombosis
CountriesUnited States
CollaboratorsTransonic Systems Inc.

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 3, 2015
Enrollment StartMar 1, 2015
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 11.3 years ago

Interventions

Transonicdevice

Access recirculation, access flow would be determined using the ultrasound dilution technique (Transonic system). 1. Within 90 min of the beginning of HD session HD03 sensors are clamped HD tubing lines 2. Recirculation, access flow will be performed according to HD03 Manual. 3. Post intervention evaluation is as per each arm follow up unless other follow up deemed necessary by the interventionalist.